A study of the Beacon platform for laser prostate surgery
Part of Kidney & urinary clinical trials.
This trial tests a new tool (the Beacon Platform) that helps doctors perform a type of laser surgery for an enlarged prostate, called HoLEP. The goal is to see if it makes the surgery easier and more effective, which could help you urinate better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be male and at least 45 years old.
- You need to have urinary symptoms or trouble emptying your bladder because of an enlarged prostate.
- Your prostate must be between 30 and 120 cc, based on a recent scan (ultrasound, MRI, or CT).
- You should not have had previous prostate surgery, such as TURP, laser treatment, or a prostate lift.
- You must be able to stop blood thinners (except low-dose aspirin) for a few days before the procedure.
- You must not have prostate or bladder cancer, and your BMI should be 35 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different laser techniques (HoLEP and ThuLEP) for treating an enlarged prostate that's causing urinary symptoms. Both are minimally invasive surgical options; the trial will help determine which works better for symptom relief.
This trial tests a new surgical platform called Beacon during HoLEP, a common procedure to treat enlarged prostate symptoms. It may help men with difficulty urinating due to an enlarged prostate.
This study measures how much prostate tissue is removed during a minimally invasive laser surgery (HoLEP) and tests whether the amount removed can predict how much your urinary symptoms improve. Understanding this connection may help doctors better predict surgery outcomes for men with urinary problems.
This study compares two minimally invasive procedures for treating an enlarged prostate: one uses a laser (holmium enucleation) and the other uses a robotic water jet. The goal is to see which treatment better improves urinary symptoms caused by an enlarged prostate.
This trial compares Aquablation with a laser procedure (HoLEP) to improve urinary symptoms caused by an enlarged, non-cancer prostate. It may help you understand which treatment works better for symptom relief in men with medium-to-large prostates.
This trial looks at whether doing a prostate “laser procedure” (called HoLEP) before starting radiation and hormone therapy can improve severe urinary symptoms and reduce urine retention problems. It is for people with prostate cancer who are planning radiation plus hormone treatment and who have significant bladder/urinary trouble.
Hear when a new BPH (Benign Prostatic Hyperplasia) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.